LDR | |
01248cam a2200289 i 4500 |
001 |
|
101836500 |
003 |
|
MiAaHDL |
005 |
|
20170327000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
760501s1976 xx f00000 eng d |
035 |
⊔ |
⊔ |
‡asdr-ucr.b16852217
|
040 |
⊔ |
⊔ |
‡aSTU
‡cSTU
‡dGPO
|
043 |
⊔ |
⊔ |
‡an-us---
|
049 |
9 |
9 |
‡aRECLAMATION
|
074 |
⊔ |
⊔ |
‡a507-L-2
|
086 |
⊔ |
⊔ |
‡aHE 20.3502:An 8
|
098 |
⊔ |
⊔ |
‡aHE203502An8
|
099 |
⊔ |
8 |
‡aHE 20.3502:An 8
|
035 |
⊔ |
⊔ |
‡a(OCoLC)2158743
|
110 |
2 |
0 |
‡aNational Institute of Neurological and Communicative Disorders and Stroke.
|
245 |
1 |
0 |
‡aAnticonvulsant screening project; Antiepileptic drug development program /
‡cEpilepsy Branch, Neurological Disorder Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health.
|
260 |
0 |
⊔ |
‡aBethesda, Md. :
‡bU.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Neurological and Communicative Disorders and Stroke,
‡c1976.
|
300 |
⊔ |
⊔ |
‡a[14] p. :
‡bill. ;
‡c24 cm.
|
490 |
0 |
⊔ |
‡aDHEW publication ; no. (NIH) 76-1093.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aAnticonvulsants.
|
CID |
⊔ |
⊔ |
‡a101836500
|
DAT |
0 |
⊔ |
‡a19921101101731.0
‡b20170327000000.0
|
DAT |
1 |
⊔ |
‡a20170329090731.0
‡b2023-10-01T17:55:06Z
|
DAT |
2 |
⊔ |
‡a2023-10-01T17:30:02Z
‡b2019-09-29T20:00:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-UCR
‡dIII - MILLENIUM
‡lprepare.pl-004-007
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-ucr.b16852217
‡auc1
‡bSDR
‡cUCR
‡puc1.31210024850669
‡sUC
‡1.b16852217
|
974 |
⊔ |
⊔ |
‡bUC
‡cUCR
‡d20231001
‡sgoogle
‡uuc1.31210024850669
‡y1976
‡rpdus
‡qgfv
|